News & Views
Chinese FDA clearance for the IDS-iSYS instrument
Oct 25 2014
Immunodiagnostic Systems Holdings PLC (IDS) has received notice that the China Food and Drug Administration (“CFDA”) has approved the company's IDS-iSYS automated immunoassay instrument for sale in the Chinese market.
In May 2013 IDS appointed Beijing Leadman Biochemistry Technology Co Ltd as its exclusive distributor for the IDS-iSYS instrument and assays in the People's Republic of China. Since May 2013 IDS have been working closely with Leadman on CFDA clearance for the IDS-iSYS instrument as well as a number of Leadman and IDS automated immunoassays for use on the IDS-iSYS.
Patrik Dahlen CEO of IDS commented, "We are delighted to receive the CFDA clearance of the IDS-iSYS instrument within our projected timeframe. This approval is a key milestone in allowing us to access the large and fast growing Chinese diagnostic market. The next step is to gain CFDA approval for the automated assays for use on the IDS-iSYS and we continue to work closely with our Chinese partner, Leadman, in order to achieve this.”
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan